CHROMATOGRAPHIC METHOD FOR THE DETECTION OF DRUGS

Abstract: A chromatographic plate for use in thin-layer chroma­ tography for the detection of drugs in a physiological medium comprises an inert substrate and an adsorbent material impregnated with a heavy metal oxidising agent, preferably a vanadium salt, which chemically reacts with a broad range of drugs, preferably basic amine-containing drugs, in the presence of a strong acid reagent, preferably concentrated sulphuric acid, to produce a characteristic colour on the chromatographic plate. The steps of extracting the drug from the physiological medium, introducing the drug to the chromatographic plate and developing the chromatographic plate are conventional, but by including the heavy metal oxidising reagent on the chromatographic plate the detection of the drugs can be carried out simply by exposure to the strong acid reagent.

Description: DESCRIPTION "IMPREGNATED SUBSTRATE FOR CHROMATOGRAPHIC ASSAYS" The present invention is concerned with improved methods of visualizing drugs employing thin layer chromatography. Many of the reagents employed for visualizing a drug on a chromatograph are unstable and must be freshly or frequently prepared. This can be a time consuming job and create inefficiencies in the clinical laboratory. The problem of unstable reagents is exemplified by Mandelin's reagent. Mandelin's reagent turns green on standing. Preparation of fresh batches can result in batch-to-batch variations, with variations in the resulting colours. Thus, comparison with photographic standards is difficult. Thin-layer chromatography is a versatile and economical method for the detection of a wide variety of drugs in physiological media. One particular technique is described in U.S. Patent No. 3,714,035, involving a chromatographic plate with a plurality of scored areas into which are introduced one or more sample discs and standardized discs having a known amount of specific drugs. By developing the sample and standards simultaneously one can compare the sample spots to the standard spots and make an accurate determination of whether a specific drug is present and, if present, the amount thereof. An improvement to this technique is described in U.S. Patent No. 3,963,421, which describes an improved method of extracting the sample. According to the invention articles and methods are provided for thin layer chromatography, where a metal ion containing reagent is employed for visualizing a drug on the chromatograph. The metal ion is impregnated into at least the relevant portion of the chromatograph. After chromatographing the sample, the drug is visualized, by subjecting the relevant portion to the remaining components of the reagent. In more detail the invention provides a chromatographic plate for use in thin-layer chromatographic detection of drugs in a physiological medium wherein said drug is visualized by exposure to a heavy metal ion in the presence of a strong acid reagent, said plate comprising an inert substrate and an adsorbent material on the substrate, characterised in that the adsorbent material is impregnated with a heavy metal ion containing reagent at a concentration sufficient to react with the drug in the presence of the acid reagent to produce a characteristic visual response. In a preferred embodiment, the vanadium salt of Mandelin's reagent is impregnated in the absorbent material (e.g. silica gel) on a chromatographic plate. Adsorbent discs are prepared and placed on the plate, and the plate is developed in the known manner, described hereinabove. The detection of the colour spots may then be accomplished by exposing the chromatographic plates to concentrated sulphuric acid. Thus, the necessity of preparing Mandelin's reagent at the time of assay has been eliminated. The thin-layer chromatographic technique of the present invention involves the five basic steps common to all thin-layer chromatographic analysis. The steps are: (1) extraction of a drug from a physiological sample, (2) concentration of the drug, (3) transfer of the concentrated drug to a chromatographic plate, (4)development of the plate, and (5) detection of the drug on the plate by visualization of the drug using a specific detection reagent. The invention lies in the manner of visualizing the drug samples after chromatographing. Each step of the technique will be described in connection with the detection of basic amine-containing drugs where Mandelin's reagent is the detection reagent. Normally, the physiological sample will be either urine or serum, depending upon the drug of interest. The sample is introduced into an extraction vessel containing a salt-halocarbon organic extractant solvent system which is typically granular sodium tungstate or molybdate for basic and neutral drugs. The organic extractant, which preferentially dissolves the drugs of interest, is of lower density than the final aqueous solution and it may be conveniently separated therefrom. Once separated, drugs may be incrementally transferred to a small absorbent disc from which the organic solvent is evaporated. A thin-layer chromatographic plate is employed which has a substantially inert substrate, e.g. a glass fibre, which can withstand sulphuric acid treatment and will not interfere with the development of the chromatographic plate. The adsorbent will usually be silica gel, but other adsorbents may also find application, such as alumina. The chromatographic plate will typically have one or more scored areas which are aligned adjacent one end of the chromatograph, although the detection technique will work equally well for plates which do not include the scored areas of U.S. Patent No. 3,714,037, described hereinabove. One of the scored areas is for receiving the sample adsorbent disc prepared as described above. The other scored areas receive "standardized" discs which have known amounts of specific drugs. The chromatograph is developed by placing the end adjacent the scored areas in a small amount of developing solution. As the developing solution moves up the chromatograph, the various drugs will migrate from the discs upward with the developing solution. After a sufficient time for development, the chromatographic plate is removed from the solution and the solution is allowed to evaporate to leave a drug chromatographic plate. After development, it is necessary to treat the chromatographic plate to detect or visualize the progression of the drugs along the chromatographic plate. By comparing the spots of the sample1 as to size and colour, with the spots of the standards, one can make a semi-quantitative determination of the approximate amount of a particular drug in the sample. As described hereinabove, basic amine-containing drugs are typically detected by exposing the chromatographic plate to Mandelin's reagent, comprising a pentavalent vanadium salt in concentrated sulphuric acid. The problems associated with Mandelin's reagent were also set forth previously. In accordance with the present invention, the excellent developing characteristics of Mandelin's reagent are achieved by applying concentrated sulphuric acid to a chromatographic plate impregnated with a sufficient concentration of vanadium salt. A vanadium-impregnated plate of the present invention can be prepared by exposing silica gel, conveniently supported by a glass fibre support, to a vandium salt solution. Individual frames of¯the paper may be dipped in the vanadium solution or a continuous web of the paper passed through the solution. At convenient vanadium concentrations, an exposure time of several seconds has been found adequate to obtain the necessary concentration of vanadium salt on the plate. After drying, the vanadium-impregnated paper web may be cut up into chromatographic plates. Various water soluble vanadium salts may be used. Three vanadium salts are of particular interest in the prevent invention. They are vanadium pentoxide (V205), vanadyl sulphate (VOSO4) and ammonium metavanadate (NH4VO3). Ammonium metavanadate is the vanadium salt typically used in making Mandelin's reagent. The vanadium solutions employed are aqueous and of a vanadium salt concentration in the range of from approximately 0.02 to 1.0% weight/ volume percent, with a preferred range of from approximately 0.08 to 0.1 weight/volume percent. The detection of drugs on the vanadiumimpregnated chromatographic paper is achieved by exposing the chromatographic plate to concentrated sulphuric acid. Typically, the plate will be dipped in the concentrated sulphuric acid, although spraying the plate with a mist of sulphuric acid is also possible. The description of the present invention in relation to Mandelin's reagent is for exemplary purposes only and the scope of the invention is not intended to be limited thereby. Rather, the invention applies to any detection reagent which comprises two or more components. including a heavy metal ion, wherein the heavy metal ion is impregnated directly onto adsorbent material on the chromatographic plate, rather than included in the detection reagent. This is particularly true with oxidizing heavy metal ions used in conjunction with a strong or concentrated mineral acid. The characteristic reaction associated with the detection of the drug may then take place by contacting the plate with the acid.

Claims: CLAIMS 1. A chromatographic plate for use in thinlayer chromatographic detection of drugs in a physiological medium wherein said drug is visualized by exposure to a heavy metal ion in the presence of a strong acid reagent, said plate comprising an inert substrate and an adsorbent material on the substrate, characterised in that the adsorbent material is impregnated with a heavy metal ion containing reagent at a concentration sufficient to react with the drug in the presence of the acid reagent to produce a characteristic visual response. 2. A chromatographic plate according to claim 1, wherein said heavy metal ion containing reagent is a vanadium salt and the reagent is concentrated sulphuric acid. 3. Use of a chromatographic plate as claimed in claim 1 or 2 in the chromatographic assay of a physiological specimen for a drug, where after migration of said drug on a chromatographic plate, said drug is detected by observing a characteristic reaction of said drug with a heavy metal oxidizing reagent in the presence of a strong acid reagent. 4. A method for producing a chromatographic plate as claimed in claim 1 or 2, the method comprising impregnating the adsorbent material of a thin layer chromatograph with a sufficient concentration of a heavy metal oxidizing reagent in sufficient amount for reaction to proceed in the presence of a strong acid reagent with drug present on said adsorbent material. 5. A method according to claim 4, wherein the heavy metal reagent is a vanadium salt and the strong acid reagent is concentrated sulphuric acid. 6. A method according to claim 4 or 5, wherein the adsorbent material is impregnated by exposing the chromatographic plate to an aqueous solution of the vanadium salt having a concentration of from 0.02 to 1.0 weight/volume percent.

Inventors: JONES, DONALD W.
Applicants: MARION LABORATORIES INC
Application year: 1982
Main classification: G01N30
IPC codes: G01N33, G01N30